GSK, Boehringer Put Profits Over User Safety, Zantac Jury Told
Share!
Insurance Journal - May 06, 2024
Drugmakers GSK Plc and Boehringer Ingelheim GmbH prioritized profits over consumer safety by hiding the cancer risks of their once-blockbuster heartburn drug Zantac, according to lawyers representing a Chicago woman in the first of thousands of such claims to go …...
Recommended Articles
People Moves: AXA XL Promotes Riha as Chief Client & Distribution Officer, APAC/Europe
Posted: May 17, 2024
AXA XL Promotes Riha as Chief Client & Distribution Officer, APAC & Europe AXA XL announced...
Security First Touts 5% Rate Decrease for HO-3, Renters Policies in Florida
Posted: May 17, 2024
Citing the stabilizing impact that legislative reforms have had on the Florida market, Security Firs...
Kansas Governor Cites Competition Concerns While Vetoing Bill for School Gun-Detection Technology
Posted: May 17, 2024
Kansas Gov. Laura Kelly vetoed a measure Wednesday that could have earmarked up to $5 million for gu...